Jun. 8 at 2:14 AM
$CABA $NVDA $TSLA $AMZN $PLUG
$CABA EULAR data added to an already impressive autoimmune CAR-T dataset.
✅ 50+ evaluable patients across lupus, myositis and systemic sclerosis
✅ Encouraging early preconditioning-free lupus findings
✅ Continued evidence supporting a one-time immune reset approach
The science continues to advance while the stock remains heavily oversold. The market may not react immediately, but the dataset keeps expanding, management continues to execute, and the autoimmune opportunity remains massive.
This week brings investor conference appearances and the annual shareholder meeting, keeping attention on the story. Watching for increased focus on the growing patient dataset, preconditioning-free lupus program, and the broader small-cap biotech rotation.
Sometimes the stock lags the science. Eventually the market catches up.
There you go a 10 X stock
Mark it !!!
Grab some
$PLUG also and thank me later 
#MegaTechSellOff /rotation 
